Examples of 'bortezomib hospira' in a sentence
Meaning of "bortezomib hospira"
Bortezomib Hospira is a particular brand or version of the drug bortezomib. Bortezomib is a medication used in chemotherapy to treat certain types of cancer, such as multiple myeloma or mantle cell lymphoma. The inclusion of 'Hospira' indicates the manufacturer or supplier of this specific form of the drug
How to use "bortezomib hospira" in a sentence
Basic
Advanced
bortezomib hospira
Bortezomib Hospira should not be administered intrathecally.
It is not intended to provide practical advice on how to use Bortezomib Hospira.
Bortezomib Hospira is for single use only.
Antiviral prophylaxis is recommended in patients being treated with Bortezomib Hospira.
Bortezomib Hospira must be reconstituted by a healthcare professional.
Instructions for reconstitution Bortezomib Hospira must be reconstituted by a healthcare professional.
Bortezomib Hospira is for intravenous or subcutaneous use.
There have been fatal cases of inadvertent intrathecal administration of Bortezomib Hospira.
Bortezomib Hospira must not be given by other routes.
What you need to know before you use Bortezomib Hospira.
Bortezomib Hospira should not be given by other routes.
If you are given too much Bortezomib Hospira.
Bortezomib Hospira contains the active substance bortezomib.
The Committee recommended that Bortezomib Hospira be approved for use in the EU.
Bortezomib Hospira should be discontinued if serious reactions occur.
See also
Contents of the pack and other information What Bortezomib Hospira contains.
Bortezomib Hospira is available for intravenous or subcutaneous administration.
What you need to know before you use Bortezomib Hospira Do not use Bortezomib Hospira.
Bortezomib Hospira may have a moderate influence on the ability to drive and use machines.
Therefore, platelet counts should be monitored prior to each dose of Bortezomib Hospira.
What Bortezomib Hospira is and what it is used for.
It is recommended that patients receive 2 cycles of Bortezomib Hospira following a confirmation of a complete response.
Bortezomib Hospira therapy should be withheld.
The benefit / risk ratio should be considered prior to continuing Bortezomib Hospira therapy.
What Bortezomib Hospira looks like and contents of the pack.
Therefore, caution should be used during handling and preparation of Bortezomib Hospira.
Withhold Bortezomib Hospira treatment until symptoms of toxicity have resolved.
Table 6, Recommended starting dose modification for Bortezomib Hospira in patients with hepatic Impairment.
Change Bortezomib Hospira treatment schedule to.
Grade ≥ 3 non-haematological toxicities considered to be related to Bortezomib Hospira.
How to store Bortezomib Hospira Contents of the pack and other information.
At least 72 hours should elapse between consecutive doses of Bortezomib Hospira.
Bortezomib Hospira 3 mg powder for solution for injection.
Table 2, Recommended posology for Bortezomib Hospira in combination with melphalan and prednisone.
Bortezomib Hospira is a ‘ generic medicine.
In patients developing PRES, Bortezomib Hospira should be discontinued.
Bortezomib Hospira powder for solution for injection is a white to off-white cake or powder.
Patients should be closely monitored when given Bortezomib Hospira in combination with potent CYP3A4-inhibitors.
For Bortezomib Hospira dosage adjustments, dose modification guidelines described for monotherapy should be followed.
Fertility studies were not conducted with Bortezomib Hospira see section 5.3.
Note, Bortezomib Hospira is a cytotoxic agent.
At least 72 hours must pass between two doses of Bortezomib Hospira.
How has Bortezomib Hospira been studied?
Bortezomib Hospira contains the active substance bortezomib, a so-called ‘ proteasome inhibitor.
When toxicity resolves re-initiate Bortezomib Hospira treatment and reduce dose to 0.7 mg/m2 once per week.
Bortezomib Hospira 3.5 mg powder for solution for injection is for intravenous or subcutaneous use.
Cells / μL on a Bortezomib Hospira dosing day other than Day 1 of each cycle.
Bortezomib Hospira 3.5 mg powder for solution for injection is available for intravenous or subcutaneous administration.
Why is Bortezomib Hospira approved?
Bortezomib Hospira must be reconstituted by a healthcare professional ( see section 6.6 ).
You'll also be interested in:
Examples of using Bortezomib
Show more
Bortezomib powder has to be dissolved before administration
The numbers indicate the concentration of bortezomib in nM
Bortezomib should be discontinued if serious reactions occur
Examples of using Hospira
Show more
Hospira says it plans to mitigate these concerns in future products
A doctor or a nurse will administer you Levetiracetam Hospira as an intravenous infusion
Hospira is the largest producer of generic injectable pharmaceuticals in the world
